SOX2 expression in relapsed GBM patients with TMZ chemotherapy was higher than that in primary GBM patients (Fig. 3k), and a positive correlation was noted between SOX2OT and SOX2 (Fig. 3l). This evidence concerns the gene SOX2 and glioblastoma.